BROOKE BANOS: Open Payments
NPI 1609419068 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 30 payments from 11 companies in 2025. Trend: 2023 $307 · 2024 $433 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $128 |
| Novo Nordisk Inc | 1 | $120 |
| Edwards Lifesciences Corporation | 1 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $47 |
| PFIZER INC. | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| BIOTRONIK INC. | 1 | $32 |
| AtriCure, Inc. | 1 | $30 |
Products named: Ozempic, SAPIEN 3 Ultra RESILIA, CAMZYOS, SOLITAIRE X, FARXIGA, LifeVest, NEXLETOL, ELIQUIS.
Industry payments across MD — which companies pay providers there.
